Reporting of side effects and additional monitoring
▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See www.mhra.gov.uk/yellowcard for how to report side effects. Side effects should also be reported to Bristol-Myers Squibb Medical Information on 0800 731 1736 or email@example.com.
*Advanced (unresectable or metastatic)
**Advanced (locally advanced or metastatic)
NSCLC - Non-small cell lung cancer
RCC - renal cell carcinoma
Date of preparation: April 2016
The page at www.opdivo.co.uk says:
You are now leaving the OPDIVO UK website.
Do you wish to continue?